Substances use between early and later stages of the COVID-19 pandemic in Israel 1/5 doi.org/10.1186/s13584…
AIMS: Only several empirical studies have examined substance use during the COVID-19 pandemic in general populations. Most of these studies compared self-reported substances use before the pandemic and during the pandemic's early stages. Th... 2/5
is study aims to identify the changes in substance use between the early and later waves of the COVID-19 pandemic in Israel.METHODS: A cross-sectional online survey recruited 750 participants (ages 18-65) in two waves: (1) 427 during and fo... 3/5
llowing the first lockdown (April-mid-May, 2020); and (2) 323 following the second lockdown (from October to mid-November, 2020).RESULTS: Participants who experienced two lockdowns reported more frequent consumption of all alcoholic beverag... 4/5
Date: August 2021 Authors: Hagit Bonny-Noach, Keren Cohen-Louck, Inna Levy 5/5
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Case Report: CBD Cigarettes for #HarmReduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder 1/5 doi.org/10.3389/fpsyt.…
The treatment of patients with schizophrenia and substance use disorder poses a challenge for clinicians. Continued use of cannabis and cocaine can exacerbate psychotic symptoms and worsen the course of disease. To date, no pharmacotherapy ... 2/5
is available for patients with cannabis use disorder (CUD). Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the main active constituents in Cannabis sativa, with the latter being linked to an increased risk of psychosis. We describe... 3/5
"OPTIONS-DC", a feasible discharge planning conference to expand infection treatment options for people with substance use disorder 1/5 doi.org/10.1186/s12879…
BACKGROUND: Serious bacterial infections associated with substance use often result in long hospitalizations, premature discharges, and high costs. Out-of-hospital treatment options in people with substance use disorder (SUD) are often limi... 2/5
ted.METHODS: We describe a novel multidisciplinary and interprofessional care conference, "OPTIONS-DC," to identify treatment options agreeable to both patients and providers using the frameworks of #harmreduction and patient-centered care.... 3/5
Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study 1/5 doi.org/10.1186/s12879…
BACKGROUND: Estonia has a typical Eastern European HIV epidemic where the most frequent co-infection is chronic hepatitis C (HCV). We aimed to describe the changes in HCV prevalence, the distribution of HCV genotypes (GT), and HCV treatment... 2/5
in Estonian people living with HIV over 15 years.METHODS: We used data of subjects included to the Estonian HIV Cohort Study (E-HIV) before 31st of December 2015. We compared two time periods-first, 1st of January 2000 to 31st of December ... 3/5
One Health faces enormous pressure and challenges as it attempts to mitigate dynamic, surprising and complex global events that threaten the health and sustainability of human and animal populations and the biosphere. One Health practitione... 2/5
rs and researchers need every advantage to developing working solutions to the world's imminent complex issues. Heath promotion and #harmreduction, interrelated approaches that have seen much success over decades of use in global public hea... 3/5
Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings 1/5 doi.org/10.1136/bmjope…
OBJECTIVES: People who inject drugs (PWID) play an integral role in facilitating the entry of others into injection drug use (IDU). We sought to assess factors influencing PWID in providing IDU initiation assistance across three distinct No... 2/5
rth American settings and to generate pooled measures of risk.DESIGN: We employed data from three PWID cohort studies participating in PReventing Injecting by Modifying Existing Responses (PRIMER), for this cross-sectional analysis.SETTING:... 3/5
Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination Goal 1/5 doi.org/10.3389/fmicb.…
Little is known about the distribution of hepatitis C virus (HCV) genotypes among people who inject drugs (PWID) in North African countries, including Tunisia. This study aims to describe HCV genotypes circulating among Tunisian PWID. A cro... 2/5
ss-sectional study was conducted, and 128 HCV-positive PWID were recruited between 2018 and 2019 from community-based #harmreduction centers. After informed consent, sociodemographic characteristics and risk behavior data were obtained usin... 3/5